HomeCompareGRAMF vs JNJ

GRAMF vs JNJ: Dividend Comparison 2026

GRAMF yields 1260.24% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GRAMF wins by $145577708.51M in total portfolio value
10 years
GRAMF
GRAMF
● Live price
1260.24%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$145577708.54M
Annual income
$125,922,093,282,162.45
Full GRAMF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — GRAMF vs JNJ

📍 GRAMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGRAMFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GRAMF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GRAMF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GRAMF
Annual income on $10K today (after 15% tax)
$107,120.35/yr
After 10yr DRIP, annual income (after tax)
$107,033,779,289,838.08/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, GRAMF beats the other by $107,033,779,285,800.69/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GRAMF + JNJ for your $10,000?

GRAMF: 50%JNJ: 50%
100% JNJ50/50100% GRAMF
Portfolio after 10yr
$72788854.28M
Annual income
$62,961,046,643,456.16/yr
Blended yield
86.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GRAMF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
0.1
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GRAMF buys
0
JNJ buys
0
No recent congressional trades found for GRAMF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGRAMFJNJ
Forward yield1260.24%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$145577708.54M$30.5K
Annual income after 10y$125,922,093,282,162.45$4,749.88
Total dividends collected$144119665.53M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: GRAMF vs JNJ ($10,000, DRIP)

YearGRAMF PortfolioGRAMF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$136,724$126,023.94$10,594$274.49+$126.1KGRAMF
2$1,756,621$1,610,326.24$11,294$360.69+$1.75MGRAMF
3$21,215,447$19,335,862.56$12,133$476.91+$21.20MGRAMF
4$240,950,361$218,249,832.96$13,156$635.42+$240.94MGRAMF
5$2,574,387,483$2,316,570,596.59$14,432$854.61+$2574.37MGRAMF
6$25,886,323,605$23,131,728,998.21$16,056$1,162.76+$25886.31MGRAMF
7$245,078,964,082$217,380,597,824.75$18,175$1,604.53+$245078.95MGRAMF
8$2,185,647,996,590$1,923,413,505,021.74$21,009$2,252.68+$2185647.98MGRAMF
9$18,369,733,884,259$16,031,090,527,907.70$24,911$3,229.73+$18369733.86MGRAMF
10$145,577,708,538,319$125,922,093,282,162.45$30,458$4,749.88+$145577708.51MGRAMF

GRAMF vs JNJ: Complete Analysis 2026

GRAMFStock

TPCO Holding Corp., cultivates, extracts, manufactures, distributes, retails, and delivers cannabis in California. The company offers approximately 17 owned and licensed brands offering 250 stock keeping units across form-factors, such as jarred and bagged whole flower, pre-rolls, infused pre-rolls, bulk extracts, vaporizer cartridges, ready-to-use vapes, concentrates, gummies, chocolate, capsules, tinctures, topicals, and body care products. As of December 31, 2021, the Company operated eleven retail locations and six consumer delivery hubs; and four stores under the Caliva, Deli by Caliva, Coastal, and Calma brands, as well as through Caliva.com, a direct-to-consumer e-commerce platform. The company was formerly known as Subversive Capital Acquisition Corp. and changed its name to TPCO Holding Corp. in January 2021. TPCO Holding Corp. was incorporated in 2019 and is headquartered in San Jose, California.

Full GRAMF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this GRAMF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GRAMF vs SCHDGRAMF vs JEPIGRAMF vs OGRAMF vs KOGRAMF vs MAINGRAMF vs ABBVGRAMF vs MRKGRAMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.